Biochemistry, Genetics and Molecular Biology
Genotyping
100%
Gene Polymorphism
91%
Methylation
72%
Blood Lead Level
44%
Selenium Blood Level
35%
Folic Acid Blood Level
35%
Cyanocobalamin
35%
Single-Nucleotide Polymorphism
29%
Binding Domain
27%
Eicosanoid Receptor
27%
DNA Methylation
27%
Vitamin Blood Level
27%
Haplotype
25%
Allele
24%
X Ray
24%
Case-Control Study
19%
Bone Density
18%
XRCC1
18%
Adiponectin
18%
Alternative Splicing
18%
Metalloprotease Inhibitor
18%
High-Performance Liquid Chromatography
17%
Prevalence
15%
Autoantibodies
14%
Cross Sectional Study
13%
Adipogenesis
13%
Restriction Fragment Length Polymorphism
13%
Polymerase Chain Reaction
13%
Genetic Polymorphism
13%
Isoform
12%
Dose Response
12%
Atomic Absorption Spectroscopy
11%
MicroRNA
11%
Passive Smoking
11%
Folic Acid
11%
Glomerulus Filtration
11%
Alpha Oxidation
11%
B Cell
11%
Body Mass
10%
Methyltransferase
10%
Genetic Divergence
10%
Adipocyte
10%
Deoxycytidine
9%
Screening
9%
Clinical Trial
9%
Aldosterone Synthase
9%
Tumor Necrosis Factor Alpha
9%
DNA Methyltransferase
9%
Vascular Endothelial Growth Factor A
9%
Interleukin 8
9%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Kidney Failure
65%
Transitional Cell Carcinoma
55%
Developmental Delay
55%
Renal Cell Carcinoma
46%
Vitamin B12
31%
Folic Acid
31%
Bladder Cancer
30%
Receptor Protein
27%
Synapsin II
27%
Randomized Controlled Trial
27%
Methyltransferase
19%
Case-Control Study
19%
Interleukin 8
18%
8 Hydroxydeoxyguanosine
18%
Fragility Fracture
18%
Carbon Monoxide Poisoning
18%
Malignant Neoplasm
17%
Cohort Study
17%
Tumor Necrosis Factor
16%
High Performance Liquid Chromatography
15%
Carcinogenesis
14%
Prevalence
12%
Cardiovascular Disease
11%
Retrospective Study
11%
Neoplasm
11%
Colorectal Cancer
11%
Deoxycytidine
10%
Recurrent Disease
9%
DNA Glycosyltransferase
9%
DNA (Cytosine 5) Methyltransferase 1
9%
Tissue Inhibitor of Metalloproteinase 3
9%
Clinical Trial
9%
Carcinogenicity
9%
Uterine Cervix Cancer
9%
Nonalcoholic Fatty Liver
9%
Vasculotropin A
9%
Lesinurad
9%
Sjoegren Syndrome
9%
Feces microflora
9%
Musculoskeletal Disease
9%
Sarcopenia
9%
Mouth Carcinoma
9%
8 Hydroxyguanine
9%
5,10 Methylenetetrahydrofolate Reductase (FADH2)
9%
Sleep Disordered Breathing
9%
Cross-Sectional Study
9%
Atrial Fibrillation
9%
Zoledronic Acid
9%
Respiratory Syncytial Virus Vaccine
9%
Myeloperoxidase
9%
Medicine and Dentistry
Urinary System
56%
Methylation
55%
Clear Cell Renal Cell Carcinoma
37%
Transitional Cell Carcinoma
27%
Medicine
27%
Odds Ratio
23%
Family Practice
22%
Metabolic Syndrome
21%
Receptor Protein
18%
Sarcopenia
18%
Synapsin II
18%
4 Iodo 2,5 Dimethoxyamphetamine
18%
Chronic Kidney Disease
18%
8 Hydroxydeoxyguanosine
18%
Geriatrics
18%
Erythrocyte
11%
Bladder Cancer
11%
Sleep Quality
11%
Systematic Review
11%
Glomerular Filtration Rate
10%
Dual-Energy X-Ray Absorptiometry
10%
Middle Cerebral Artery
10%
Methyltransferase
10%
Study Subject
10%
Cardiovascular Disease
10%
Alcohol Consumption
10%
Skeletal Muscle
10%
Retrospective Study
10%
Arginine
9%
Prevalence
9%
Hepatocellular Carcinoma
9%
Screening
9%
Nocturia
9%
Tubular Adenoma
9%
Cerebral Autoregulation
9%
Clinical Trial
9%
Internal Carotid Artery
9%
Carcinogenicity
9%
Serum Albumin
9%
Hypoglycemia
9%
Brain Ischemia
9%
Meta-Analysis
9%
Insulin Resistance
9%
Repolarization
9%
Hypovitaminosis D
9%
Mouth Carcinoma
9%
Adolescent
9%
8-Oxoguanine
9%
Preschooler
9%
Gut
9%
